PGR and neoplasm: Moreover, clinical label enrichment analysis and additional tests applied to describe the clusters show good mapping between ClustOmics clusters and key biological clinical labels such as estrogen receptor and progesterone receptor status (ER/PR) or histological type of tumor (see Table 4).